• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4798153)   Today's Articles (2727)
For: Keeffe EB. Risk score for development of HCC: ready for use in practice? Lancet Oncol 2011;12:517-8; discussion 518-9. [PMID: 21497552 DOI: 10.1016/s1470-2045(11)70085-7] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Number Cited by Other Article(s)
1
Sun X, Wang M, Zhang F, Kong X. Inhibition of NET-1 suppresses proliferation and promotes apoptosis of hepatocellular carcinoma cells by activating the PI3K/AKT signaling pathway. Exp Ther Med 2019;17:2334-2340. [PMID: 30867719 DOI: 10.3892/etm.2019.7211] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/22/2017] [Accepted: 07/20/2018] [Indexed: 12/14/2022]  Open
2
Yang HI, Lee MH, Liu J, Chen CJ. Risk calculators for hepatocellular carcinoma in patients affected with chronic hepatitis B in Asia. World J Gastroenterol 2014;20:6244-6251. [PMID: 24876745 PMCID: PMC4033462 DOI: 10.3748/wjg.v20.i20.6244] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/02/2013] [Revised: 12/30/2013] [Accepted: 01/20/2014] [Indexed: 02/06/2023]  Open
3
Yang H, Chen P. Predicting clinical outcome in a patient with chronic hepatitis B virus infection. Clin Liver Dis (Hoboken) 2013;2:5-7. [PMID: 30992810 PMCID: PMC6448609 DOI: 10.1002/cld.158] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]  Open
4
Chen CJ, Yang HI. Risk score for development of HCC: ready for use in practice? – Authors' reply. Lancet Oncol 2011. [DOI: 10.1016/s1470-2045(11)70121-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
PrevPage 1 of 1 1Next
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Excel